-
1
-
-
33646245937
-
Adaptive designs in clinical drug development-An executive summary of the PhRMA working group
-
Gallo P, Chuang-Stein C, Dragalin V, et al. Adaptive designs in clinical drug development-An executive summary of the PhRMA working group. J Biopharm Stat. 2006 ; 16: 275-83
-
(2006)
J Biopharm Stat
, vol.16
, pp. 275-283
-
-
Gallo, P.1
Chuang-Stein, C.2
Dragalin, V.3
-
3
-
-
36249017451
-
Adaptive designs in clinical drug development: Opportunities, challenges, and scope reflections following PhRMA's November 2006 workshop
-
DOI 10.1080/10543400701643764, PII 785294562
-
Krams M, Burman CF, Dragalin V, et al. Adaptive designs in clinical drug development: Opportunities, challenges, and scope reflections following PhRMA's November 2006 workshop. J Biopharm Stat. 2007 ; 17: 957-64 (Pubitemid 350135823)
-
(2007)
Journal of Biopharmaceutical Statistics
, vol.17
, Issue.6
, pp. 957-964
-
-
Krams, M.1
Burman, C.-F.2
Dragalin, V.3
Gaydos, B.4
Grieve, A.P.5
Pinheiro, J.6
Maurer, W.7
-
4
-
-
44949171503
-
Adaptive design methods in clinical trials-A review
-
Chow SC, Chang M. Adaptive design methods in clinical trials-A review. Orphanet J Rare Dis. 2008 ; 3: 11
-
(2008)
Orphanet J Rare Dis
, vol.3
, pp. 11
-
-
Chow, S.C.1
Chang, M.2
-
5
-
-
46349091495
-
Adaptive Clinical Trials: Progress and Challenges
-
DOI 10.2165/00126839-200809040-00003
-
Coffey CS, Kairalla JA. Adaptive clinical trials: Progress and challenges. Drugs R D. 2008 ; 9 (4). 229-42 (Pubitemid 351920122)
-
(2008)
Drugs in R and D
, vol.9
, Issue.4
, pp. 229-242
-
-
Coffey, C.S.1
Kairalla, J.A.2
-
6
-
-
66249141976
-
Adaptivity in drug discovery and development
-
Bretz F, Branson M, Burman CF, Chuang-Stein C, Coffey CS. Adaptivity in drug discovery and development. Drug Dev Res. 2009 ; 70: 169-90
-
(2009)
Drug Dev Res
, vol.70
, pp. 169-190
-
-
Bretz, F.1
Branson, M.2
Burman, C.F.3
Chuang-Stein, C.4
Coffey, C.S.5
-
7
-
-
65649093620
-
Adaptive designs for confirmatory clinical trials
-
Bretz F, Koenig F, Brannath W, Glimm E, Posch M. Adaptive designs for confirmatory clinical trials. Stat Med. 2009 ; 28: 1181-217
-
(2009)
Stat Med
, vol.28
, pp. 1181-1217
-
-
Bretz, F.1
Koenig, F.2
Brannath, W.3
Glimm, E.4
Posch, M.5
-
8
-
-
33750854903
-
Adaptive designs: Terminology and classification
-
Dragalin V. Adaptive designs: Terminology and classification. Drug Inf J. 2006 ; 40: 425-35 (Pubitemid 44721120)
-
(2006)
Drug Information Journal
, vol.40
, Issue.4
, pp. 425-435
-
-
Dragalin, V.1
-
9
-
-
77954875817
-
-
Food and Drug Administration Draft guidance (accessed 7 July 2010)
-
Food and Drug Administration. Guidance for industry: Adaptive design clinical trials for drugs and biologics, 2010. Draft guidance. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM201790.pdf (accessed 7 July 2010).
-
(2010)
Guidance for Industry: Adaptive Design Clinical Trials for Drugs and Biologics
-
-
-
11
-
-
33644597596
-
The continual reassessment method for dose-finding studies: A tutorial
-
Garrett-Mayer E. The continual reassessment method for dose-finding studies: A tutorial. Clin Trials. 2006 ; 3: 57-71
-
(2006)
Clin Trials
, vol.3
, pp. 57-71
-
-
Garrett-Mayer, E.1
-
12
-
-
36248961734
-
Innovative approaches for designing and analyzing adaptive dose-ranging trials
-
DOI 10.1080/10543400701643848, PII 785296533
-
Bornkamp B, Bretz F, Dmitrienko A, et al. Innovative approaches for designing and analyzing adaptive dose-ranging trials. J Biopharm Stat. 2007 ; 17: 965-95 (Pubitemid 350135825)
-
(2007)
Journal of Biopharmaceutical Statistics
, vol.17
, Issue.6
, pp. 965-995
-
-
Bornkamp, B.1
Bretz, F.2
Dmitrienko, A.3
Enas, G.4
Gaydos, B.5
Hsu, C.-H.6
Konig, F.7
Krams, M.8
Liu, Q.9
Neuenschwander, B.10
Parke, T.11
Pinheiro, J.12
Roy, A.13
Sax, R.14
Shen, F.15
-
13
-
-
0242694372
-
ASTIN: An adaptive dose-response study of UK-279,276 in acute ischemic stroke
-
Krams M, Lees KR, Hacke W, et al. ASTIN: An adaptive dose-response study of UK-279,276 in acute ischemic stroke. Stroke. 2003 ; 34: 2543-49
-
(2003)
Stroke
, vol.34
, pp. 2543-2549
-
-
Krams, M.1
Lees, K.R.2
Hacke, W.3
-
14
-
-
84864292858
-
-
Hinkelmann K, ed. Hoboken, NJ: John Wiley & Sons
-
Zhang L, Rosenburger W Design and Analysis of Experiments, Special Designs and Applications. Vol. 3. Hinkelmann K, ed. Hoboken, NJ: John Wiley & Sons ; 2012: 251-282.
-
(2012)
Design and Analysis of Experiments, Special Designs and Applications. Vol. 3
, pp. 251-282
-
-
Zhang, L.1
Rosenburger, W.2
-
15
-
-
66349125688
-
Adaptive patient enrichment designs in therapeutic trials
-
Wang SJ, Hung HMJ, O'Neill RT. Adaptive patient enrichment designs in therapeutic trials. Biom J. 2009 ; 51: 358-74
-
(2009)
Biom J
, vol.51
, pp. 358-374
-
-
Wang, S.J.1
Hmj, H.2
O'Neill, R.T.3
-
16
-
-
78449283356
-
Enrichment of clinical study populations
-
Temple R. Enrichment of clinical study populations. Clin Pharmacol Ther. 2010 ; 88: 774-78
-
(2010)
Clin Pharmacol Ther
, vol.88
, pp. 774-778
-
-
Temple, R.1
-
17
-
-
84859224484
-
Potential of adaptive clinical trial designs in pharmacogenetic research
-
Van der Baan FH, Knol MJ, Klungel OH, et al. Potential of adaptive clinical trial designs in pharmacogenetic research. Pharmacogenomics. 2012 ; 13: 571-78
-
(2012)
Pharmacogenomics
, vol.13
, pp. 571-578
-
-
Van Der Baan, F.H.1
Knol, M.J.2
Klungel, O.H.3
-
18
-
-
84864238949
-
Efficacy and tolerability of rizatriptan in pediatric migraineurs: Results from a randomized, double-blind, placebo controlled trial using a novel adaptive enrichment design
-
Ho TW, Pearlman E, Lewis D, et al. Efficacy and tolerability of rizatriptan in pediatric migraineurs: Results from a randomized, double-blind, placebo controlled trial using a novel adaptive enrichment design. Cephalagia. 2012 ; 10: 750-65
-
(2012)
Cephalagia
, vol.10
, pp. 750-765
-
-
Ho, T.W.1
Pearlman, E.2
Lewis, D.3
-
19
-
-
78249272973
-
Adaptive methods: Telling 'The Rest of the Story'
-
Emerson SS, Fleming TR. Adaptive methods: Telling 'The Rest of the Story'. J Biopharm Stat. 2010 ; 20: 1150-65
-
(2010)
J Biopharm Stat
, vol.20
, pp. 1150-1165
-
-
Emerson, S.S.1
Fleming, T.R.2
-
20
-
-
66349091397
-
Sample size re-estimation in clinical trials
-
Proschan MA. Sample size re-estimation in clinical trials. Biom J. 2009 ; 51: 348-57
-
(2009)
Biom J
, vol.51
, pp. 348-357
-
-
Proschan, M.A.1
-
21
-
-
1842826262
-
On the inefficiency of the adaptive design for monitoring clinical trials
-
DOI 10.1093/biomet/90.2.367
-
Tsiatis AA, Mehta C. On the inefficiency of the adaptive design for monitoring clinical trials. Biometrika. 2003 ; 90: 367-78 (Pubitemid 39047164)
-
(2003)
Biometrika
, vol.90
, Issue.2
, pp. 367-378
-
-
Tsiatis, A.A.1
Mehta, C.2
-
22
-
-
82055200248
-
Adaptive increase in sample size when interim results are promising: A practical guide with examples
-
Mehta C, Pocock SJ. Adaptive increase in sample size when interim results are promising: A practical guide with examples. Stat Med. 2011 ; 30: 3267-84
-
(2011)
Stat Med
, vol.30
, pp. 3267-3284
-
-
Mehta, C.1
Pocock, S.J.2
-
23
-
-
22044443101
-
Two-stage sample size re-estimation based on a nuisance parameter: A review
-
DOI 10.1081/BIP-200062852
-
Proschan MA. Two-stage sample size re-estimation based on a nuisance parameter: A review. J Biopharm Stat. 2005 ; 15: 559-74 (Pubitemid 40967299)
-
(2005)
Journal of Biopharmaceutical Statistics
, vol.15
, Issue.4
, pp. 559-574
-
-
Proschan, M.A.1
-
24
-
-
33748550685
-
Sample size recalculation in Internal pilot study designs: A review
-
DOI 10.1002/bimj.200510238
-
Friede T, Kieser M. Sample size recalculation in internal pilot study designs: A review. Biom Journal. 2006 ; 4: 537-55 (Pubitemid 44367892)
-
(2006)
Biometrical Journal
, vol.48
, Issue.4
, pp. 537-555
-
-
Friede, T.1
Kieser, M.2
-
25
-
-
0033619975
-
Internal pilot studies II: Comparison of various procedures
-
DOI 10.1002/(SICI)1097-0258(1999 1230)18:24<3493::AID-SIM302>3. 0.CO;2-2
-
Zucker DM, Wittes JT, Schabenberger O, et al. Internal pilot studies II: Comparison of various procedures. Stat Med. 1999 ; 18: 3493-509 (Pubitemid 30041362)
-
(1999)
Statistics in Medicine
, vol.18
, Issue.24
, pp. 3493-3509
-
-
Zucker, D.M.1
Wittes, J.T.2
Schabenberger, O.3
Brittain, E.4
-
26
-
-
33750854113
-
Adaptive seamless phase II/III designs - Background, operational aspects, and examples
-
Maca J, Bhattacharya S, Dragalin V, et al. Adaptive seamless phase II/III designs: Background operational aspects and examples. Drug Inf J. 2006 ; 40: 463-73 (Pubitemid 44721124)
-
(2006)
Drug Information Journal
, vol.40
, Issue.4
, pp. 463-473
-
-
Maca, J.1
Bhattacharya, S.2
Dragalin, V.3
Gallo, P.4
Krams, M.5
-
28
-
-
70249116820
-
Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III
-
Kaufmann P, Thompson JLP, Levy G, et al. Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III. Ann Neurol. 2009 ; 66: 235-44
-
(2009)
Ann Neurol
, vol.66
, pp. 235-244
-
-
Kaufmann, P.1
Jlp, T.2
Levy, G.3
-
29
-
-
80051695379
-
Statistical aspects of the TNK-S2B trial of Tenecteplase versus Alteplase in acute ischemic stroke: An efficient, dose-adaptive, seamless phase II/III design
-
Levin B, Thompson JLP, Chakraborty B, et al. Statistical aspects of the TNK-S2B trial of Tenecteplase versus Alteplase in acute ischemic stroke: An efficient, dose-adaptive, seamless phase II/III design. Clin Trials. 2011 ; 8: 398-407
-
(2011)
Clin Trials
, vol.8
, pp. 398-407
-
-
Levin, B.1
Jlp, T.2
Chakraborty, B.3
-
30
-
-
33845891920
-
The design of simulation studies in medical statistics
-
DOI 10.1002/sim.2673
-
Burton A, Altman DG, Royston P, et al. The design of simulation studies in medical statistics. Stat Med. 2006 ; 25: 4279-92 (Pubitemid 46023772)
-
(2006)
Statistics in Medicine
, vol.25
, Issue.24
, pp. 4279-4292
-
-
Burton, A.1
Altman, D.G.2
Royston, P.3
Holder, R.L.4
-
31
-
-
33645852575
-
A two-stage design for a phase II clinical trial of coenzyme Q10 in ALS
-
DOI 10.1212/01.wnl.0000201182.60750.66, PII 0000611420060314000011
-
Levy G, Kaufmann P, Buchsbaum R, et al. A two-stage design for a phase II clinical trial of coenzyme Q10 in ALS. Neurology. 2006 ; 66: 660-63 (Pubitemid 43739818)
-
(2006)
Neurology
, vol.66
, Issue.5
, pp. 660-663
-
-
Levy, G.1
Kaufmann, P.2
Buchsbaum, R.3
Montes, J.4
Barsdorf, A.5
Arbing, R.6
Battista, V.7
Zhou, X.8
Mitsumoto, H.9
Levin, B.10
Thompson, J.L.P.11
-
32
-
-
33750884934
-
Confidentiality and trial integrity issues for adaptive designs
-
Gallo P. Confidentiality and trial integrity issues for adaptive designs. Drug Inf J. 2006 ; 4: 445-50
-
(2006)
Drug Inf J
, vol.4
, pp. 445-450
-
-
Gallo, P.1
-
33
-
-
70350139975
-
Good practices for adaptive clinical trials in pharmaceutical product development
-
Gaydos B, Anderson KB, Berry D, et al. Good practices for adaptive clinical trials in pharmaceutical product development. Drug Inf J. 2009 ; 43: 539-56
-
(2009)
Drug Inf J
, vol.43
, pp. 539-556
-
-
Gaydos, B.1
Anderson, K.B.2
Berry, D.3
-
34
-
-
84863475669
-
On the independence of data monitoring committees in adaptive design clinical trials
-
Chow SC, Corey R, Lin M. On the independence of data monitoring committees in adaptive design clinical trials. J Biopharm Stat. 2012 ; 22: 853-67
-
(2012)
J Biopharm Stat
, vol.22
, pp. 853-867
-
-
Chow, S.C.1
Corey, R.2
Lin, M.3
-
35
-
-
33750893179
-
Implementing adaptive designs: Logistical and operational considerations
-
Quinlan JA, Krams M. Implementing adaptive designs: Logistical and operational considerations. Drug Inf J. 2006 ; 40: 437-44 (Pubitemid 44721121)
-
(2006)
Drug Information Journal
, vol.40
, Issue.4
, pp. 437-444
-
-
Quinlan, J.A.1
Krams, M.2
-
36
-
-
77953666447
-
Barriers and opportunities for implementation of adaptive designs in pharmaceutical product development
-
Quinlan J, Gaydos B, Maca J, et al. Barriers and opportunities for implementation of adaptive designs in pharmaceutical product development. Clin Trials. 2010 ; 7: 167-73
-
(2010)
Clin Trials
, vol.7
, pp. 167-173
-
-
Quinlan, J.1
Gaydos, B.2
MacA, J.3
-
37
-
-
84856000206
-
NeuroNEXT: Accelerating drug development in neurology
-
NeuroNEXT: Accelerating drug development in neurology. Lancet Neurol. 2012 ; 11: 119
-
(2012)
Lancet Neurol
, vol.11
, pp. 119
-
-
-
38
-
-
84866735197
-
An overview of the adaptive designs accelerating promising trials into treatments (ADAPT-IT) project
-
Meurer WJ, Lewis RJ, Tagle D, et al. An overview of the adaptive designs accelerating promising trials into treatments (ADAPT-IT) project. Ann Emerg Med. 2012 ; 60: 451-57
-
(2012)
Ann Emerg Med
, vol.60
, pp. 451-457
-
-
Meurer, W.J.1
Lewis, R.J.2
Tagle, D.3
|